Edition:
India

SeaSpine Holdings Corp (SPNE.OQ)

SPNE.OQ on NASDAQ Stock Exchange Global Select Market

10.34USD
16 Jan 2018
Change (% chg)

$0.17 (+1.67%)
Prev Close
$10.17
Open
$10.21
Day's High
$10.39
Day's Low
$10.18
Volume
10,830
Avg. Vol
7,974
52-wk High
$13.46
52-wk Low
$6.36

Chart for

About

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion... (more)

Overall

Beta: --
Market Cap(Mil.): $143.59
Shares Outstanding(Mil.): 12.55
Dividend: --
Yield (%): --

Financials

BRIEF-Seaspine Sees FY 2017 Revenue $132 Million To $132.2 Million

* SEASPINE ANNOUNCES PRELIMINARY RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017

08 Jan 2018

BRIEF-SeaSpine Posts FDA 510(K) Clearance Of Osteoballast Demineralized Bone Matrix In Resorbable Mesh

* SEASPINE ANNOUNCES FDA 510(K) CLEARANCE OF OSTEOBALLAST™ DEMINERALIZED BONE MATRIX IN RESORBABLE MESH

30 Nov 2017

BRIEF-Seaspine Holdings reports qtrly diluted earnings per share loss‍​ $0.58

* Seaspine Holdings Corp - qtrly diluted earnings per share loss‍​ $0.58

03 Nov 2017

BRIEF-SeaSpine announces launch of Shoreline Anterior Cervical Standalone system​

* SeaSpine Holdings Corp - ‍announced full commercial launch of Shoreline Anterior Cervical Standalone system​ Source text for Eikon: Further company coverage:

26 Sep 2017

BRIEF-Seaspine Q2 revenue $34.2 mln vs I/B/E/S view $33.4 mln

* Seaspine Holdings Corp - qtrly ‍net loss per share, basic and diluted $0.68​ Source text for Eikon: Further company coverage:

04 Aug 2017

Earnings vs. Estimates